关于因 COVID-19 而限制辅助生殖技术（ART）的思考。
Considerations on the restriction of Assisted Reproductive Technology (ART) due to COVID-19.
机构信息
Department of Obstetrics and Gynecology, Columbia University Irving Medical Center/New York Presbyterian Hospital, 5 Columbus Circle PH, New York, NY 10019, United States.
Division of Reproductive Endocrinology and Infertility, Columbia University Fertility Center, United States.
出版信息
Semin Perinatol. 2020 Nov;44(7):151288. doi: 10.1016/j.semperi.2020.151288. Epub 2020 Aug 27.
The rapid rise of novel coronavirus disease 2019 (COVID-19) cases led the American Society for Reproductive Medicine (ASRM) to recommend immediate cessation of all new fertility treatment cycles on March 17, 2020. Controversial from the start, providers and patients expressed their opposition through online petitions, surveys, and other forums. While the impact of a delay in access to reproductive care is unknown, previous studies are reassuring that a delay in the timespan of months may not affect clinical outcomes. However, dropout from care during this pandemic remains a serious concern. Effective therapies against the virus and a vaccine are not on the immediate horizon. Accepting COVID-19 will likely be a part of our lives for the near future necessitates the modification of fertility protocols to keep patients, providers, and staff as safe as possible. We believe fertility treatment is an urgent, essential service that can be performed safely and responsibly during this pandemic.
新型冠状病毒病 2019（COVID-19）病例的迅速增加导致美国生殖医学学会（ASRM）于 2020 年 3 月 17 日建议立即停止所有新的生育治疗周期。从一开始就存在争议，提供者和患者通过在线请愿、调查和其他论坛表达了他们的反对意见。虽然延迟获得生殖护理的影响尚不清楚，但以前的研究令人欣慰的是，数月的时间延迟可能不会影响临床结果。然而，在大流行期间退出护理仍然是一个严重的问题。针对该病毒的有效疗法和疫苗还远未出现。在不久的将来，我们很可能会接受 COVID-19 成为我们生活的一部分，这就需要修改生育方案，以尽可能确保患者、提供者和工作人员的安全。我们认为，生育治疗是一项紧急、必要的服务，在大流行期间可以安全、负责任地进行。
Zotero 插件